ACTRIMS 2020: Post-Conference Perspectives
Investigators caution health care providers to consider specific risks of severe COVID-19 infection before initiating this therapy.
Advertisement
Advertisement
Trending on NeurologyLive
1
Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
2
2025 Women in Neurology Conference: Educating, Mentoring, and Networking
3
This Week on NeurologyLive® — September 15, 2025
4
NeurologyLive® Brain Games: September 14, 2025
5
